Erasca saw the highest growth of 3.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 3.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Erasca’s patent filings and grants. Buy the databook here.
Erasca has been focused on protecting inventions in European Patent Office(EPO) with six publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 43% of filings. The European Patent Office(EPO), Australia(AU), South Korea(KR), and Israel(IL) patent Office are among the top ten patent offices where Erasca is filings its patents..
Roche could be the strongest competitor for Erasca
For comprehensive analysis of Erasca's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.